193 related articles for article (PubMed ID: 30612975)
1. Dermatitis Herpetiformis and Celiac Disease Increase the Risk of Bullous Pemphigoid.
Varpuluoma O; Jokelainen J; Försti AK; Timonen M; Huilaja L; Tasanen K
J Invest Dermatol; 2019 Mar; 139(3):600-604. PubMed ID: 30612975
[TBL] [Abstract][Full Text] [Related]
2. Quality of Life and Gastrointestinal Symptoms in Long-Term Treated Dermatitis Herpetiformis Patients: A Cross-Sectional Study in Finland.
Pasternack C; Kaukinen K; Kurppa K; Mäki M; Collin P; Reunala T; Huhtala H; Salmi T
Am J Clin Dermatol; 2015 Dec; 16(6):545-52. PubMed ID: 26267424
[TBL] [Abstract][Full Text] [Related]
3. Bullous diseases in Malaysia: epidemiology and natural history.
Adam BA
Int J Dermatol; 1992 Jan; 31(1):42-5. PubMed ID: 1737688
[TBL] [Abstract][Full Text] [Related]
4. Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases.
Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Wieczfinska J; Pniewska E; Zebrowski M; Waszczykowska E; Wozniacka A; Eusebio M; Pietruczuk M; Pawliczak R
Mediators Inflamm; 2015; 2015():870428. PubMed ID: 27057091
[TBL] [Abstract][Full Text] [Related]
5. [Dermatitis herpetiformis: a review].
Ingen-Housz-Oro S
Ann Dermatol Venereol; 2011 Mar; 138(3):221-7. PubMed ID: 21397152
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a role of autoantibodies to heat shock protein 60, 70, and 90 in patients with dermatitis herpetiformis.
Kasperkiewicz M; Tukaj S; Gembicki AJ; Silló P; Görög A; Zillikens D; Kárpáti S
Cell Stress Chaperones; 2014 Nov; 19(6):837-43. PubMed ID: 24643797
[TBL] [Abstract][Full Text] [Related]
7. Dermatitis Herpetiformis: An Update on Diagnosis and Management.
Reunala T; Hervonen K; Salmi T
Am J Clin Dermatol; 2021 May; 22(3):329-338. PubMed ID: 33432477
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of collagenase and elastase activities in the blister fluids from bullous skin diseases. Comparison between dermatitis herpetiformis and bullous pemphigoid.
Oikarinen AI; Zone JJ; Ahmed AR; Kiistala U; Uitto J
J Invest Dermatol; 1983 Sep; 81(3):261-6. PubMed ID: 6309988
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland.
Salmi TT; Hervonen K; Kautiainen H; Collin P; Reunala T
Br J Dermatol; 2011 Aug; 165(2):354-9. PubMed ID: 21517799
[TBL] [Abstract][Full Text] [Related]
10. IL-17 expression in dermatitis herpetiformis and bullous pemphigoid.
Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Stasikowska-Kanicka O; Cynkier A; Sysa-Jedrzejowska A; Waszczykowska E
Mediators Inflamm; 2013; 2013():967987. PubMed ID: 23970818
[TBL] [Abstract][Full Text] [Related]
11. The role of apoptosis in the pathogenesis of dermatitis herpetiformis.
Caproni M; Torchia D; Antiga E; Degl'Innocenti D; Barletta E; Baroni G; Santucci M; Fabbri P
Int J Immunopathol Pharmacol; 2005; 18(4):691-9. PubMed ID: 16388717
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis.
Antiga E; Quaglino P; Pierini I; Volpi W; Lami G; Bianchi B; Del Bianco E; Renzi D; Baroni G; Novelli M; Ponti R; Papini M; Di Lollo S; Calabrò AS; Fabbri P; Caproni M
J Dermatol Sci; 2015 Jan; 77(1):54-62. PubMed ID: 25465638
[TBL] [Abstract][Full Text] [Related]
13. Dermatitis herpetiformis.
Plotnikova N; Miller JL
Skin Therapy Lett; 2013; 18(3):1-3. PubMed ID: 23674144
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review.
Wong SN; Chua SH
Br J Dermatol; 2002 Sep; 147(3):476-80. PubMed ID: 12207586
[TBL] [Abstract][Full Text] [Related]
15. Risk of vascular diseases in patients with dermatitis herpetiformis and coeliac disease: a long-term cohort study.
Nilsson N; Leivo J; Collin P; Koskinen I; Kaukinen K; Huhtala H; Palmio J; Reunala T; Hervonen K; Salmi T; Pasternack C
Ann Med; 2023 Dec; 55(1):2227423. PubMed ID: 37378421
[TBL] [Abstract][Full Text] [Related]
16. Expression of selected neuropeptides in pathogenesis of bullous pemphigoid and dermatitis herpetiformis.
Cynkier A; Zebrowska A; Wągrowska-Danilewicz M; Danilewicz M; Erkiert-Polguj A; Stasikowska-Kanicka O; Sysa-Jędrzejowska A; Waszczykowska E
Pol J Pathol; 2012 Mar; 63(1):31-9. PubMed ID: 22535604
[TBL] [Abstract][Full Text] [Related]
17. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.
Collin P; Salmi TT; Hervonen K; Kaukinen K; Reunala T
Ann Med; 2017 Feb; 49(1):23-31. PubMed ID: 27499257
[TBL] [Abstract][Full Text] [Related]
18. Mediators of mast cells in bullous pemphigoid and dermatitis herpetiformis.
Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Stasikowska-Kanicka O; Kulczycka-Siennicka L; Wozniacka A; Waszczykowska E
Mediators Inflamm; 2014; 2014():936545. PubMed ID: 25400334
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Delay in Dermatitis Herpetiformis in a High-prevalence Area.
Mansikka E; Salmi T; Kaukinen K; Collin P; Huhtala H; Reunala T; Hervonen K
Acta Derm Venereol; 2018 Feb; 98(2):195-199. PubMed ID: 29048096
[TBL] [Abstract][Full Text] [Related]
20. Association of bullous pemphigoid and comorbid health conditions: a case-control study.
Lee S; Rastogi S; Hsu DY; Nardone B; Silverberg JI
Arch Dermatol Res; 2021 Jul; 313(5):327-332. PubMed ID: 32647978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
